Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 12/20 | 0.64 |
| ▸ | ADRB2 known ✓ | P07550 | 11/20 | 0.64 |
| ▸ | CHRM2 known ✓ | P08172 | 3/20 | 0.64 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.64 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.63 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.63 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.63 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.64 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.64 |
| ▸ | CX3CR1 | P49238 | 1/20 | 0.64 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.64 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.63 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL5178957 | 1.00 | CHRM3 (0.64) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Fumaric Acid SCHEMBL5178943 | 1.00 | CHRM3 (0.64) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| SCHEMBL5180004 | 0.92 | CHRM3 (0.74) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| SCHEMBL8096713 | 0.92 | CHRM3 (0.74) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| SCHEMBL8096716 | 0.92 | CHRM3 (0.74) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Fumaric Acid SCHEMBL5179052 | 0.90 | CHRM3 (0.61) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Fumaric Acid SCHEMBL5179532 | 0.90 | CHRM3 (0.61) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Fumaric Acid SCHEMBL5179046 | 0.90 | CHRM3 (0.61) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Fumaric Acid SCHEMBL5179525 | 0.90 | CHRM3 (0.61) | CHRM3ADRB2CHRM2CHRM1CHRM5 | |
| Tolterodine SCHEMBL1260791 | 0.87 | CHRM3 (0.84) | CHRM3ADRB2CHRM2CHRM1CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1019358-B2 | 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION | PFIZER HEALTH AB (SE) | 2007-09-12 | — | — | EP | disclosed |
| EP-1019358-B1 | 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION | PHARMACIA AB (SE) | 2003-05-07 | — | — | EP | disclosed |
| US-6313132-B1 | FOR THERAPY OF URINARY INCONTINENCE, ACETYLCHOLINE-MEDIATED DISORDER | PHARMACIA AB (SE) | 2001-11-06 | — | — | US | disclosed |